| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |